# Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea

> **NCT00617903** · PHASE2 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 83 (actual)

## Conditions studied

- Papulopustular Rosacea

## Interventions

- **DRUG:** Azelaic acid
- **DRUG:** Vehicle foam

## Key facts

- **NCT ID:** NCT00617903
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2020-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00617903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00617903, "Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00617903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*